ArticleFrontiers in endocrinology2022

General Commentary: Alendronate Use and Risk of Type 2 Diabetes: A Nationwide Nested Case-Control Study.

Burkhard MuchePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.